Pfizer’s Talzenna/Xtandi Combo Hits On OS Endpoint In Prostate Cancer

 
• By Jessica Merrill
  
Pfizer announced positive overall survival data in metastatic prostate cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas